pharmaphorum3d
Kardigan raises $300m for cardio work, and other financings
In a bumper week for new biotech financings, debutante Kardigan ruled the roost with a $300 million first round that will ...
MM&M4d
Rx Rundown: Johnson & Johnson, Eli Lilly, the FDA and more
N-Power Medicine, backed by Merck GHI, announced the acquisition of Syapse Holdings. Samsung Biologics and LigaChem extended their ADC services deal. Publicis Worldwide merged with Leo Burnett to form ...
Daily Voice Nassau County NY on MSN5d
West Babylon's Forest Avenue Elementary On Chopping Block
It appears the writing’s on the chalkboard for this Long Island elementary school. The West Babylon Union Free School ...
Durham biotech startup raises $175 million as it starts novel gene therapy trial
It’s a kind of control that no one has ever tried before in patients,” Tune’s chief scientific officer said Monday.
Nintendo's best Zelda soundtrack added to music app
The Legend of Zelda: The Wind Waker has today had its soundtrack added to the Nintendo Music app. An impressive 133 tracks ...
Hosted on MSN6d
Durham startup Tune Therapeutics raises $175 million as it starts novel gene therapy trial
Launched from a Duke University lab four years ago, the biotech startup Tune Therapeutics announced a major milestone Sunday — raising $175 million in a Series B funding round to support its first ...
ncbiotech.org6d
Durham's Tune Therapeutics raises $175M in venture capital
Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 million in financing to advance a potential treatment for chronic hepatitis B and other diseases.